As HER2, DDR1/2, and EGFR are associated with metastasis of breast cancer, one could assume that the enhanced activity of these receptor tyrosine kinases mediates the enhanced migration, invasion, chemotaxis, and metastasis to bone in the AKT3 knockdown 231-BO cells. Here, EGFR is linked to breast carcinoma.